Home
About SinovacProductsPipelineInvestorsContact Us
 
 
  SITEMAP 中文版
  Investors
IR Home
President Message
Corporate Governance
Social Responsibility
Press Releases
Media Report
SEC Filings
Analyst Coverage
FAQs
Home Page
 
Social Responsibility

By the very nature of our mission - -Supply Vaccines to Eliminate Human Diseases- we are mindful of our corporate responsibility to all of our stakeholders, including patients, physicians, shareholders, employees and the communities in which we work and live.

We are driven, first and always, by our commitment to improving human health. In order to provide best-in-class vaccines to patients and physicians, the men and women of Sinovac each day demonstrate determination to innovate, develop and commercialize vaccines. To enhance the health of children in China and around the globe, we are focused on providing children with high quality vaccines.

The talents, energy and determination of each Sinovac employee enable us to do this important work. We maintain an entrepreneurial culture, in which each individual has the opportunity to make important contributions.

In addition to our commitment to patients and physicians, shareholders and employees, we support the communities in which we live and work in many other ways.

Educational Stipends
In order to promote assiduous learning and encourage social responsibility, we set up the “Chongde-Sinovac Stipend” with the College of Sciences, Beijing Normal University. Under the program, we provide educational awards to a number of enrolled postgraduates every year.

Charitable Contributions
Sinovac contributes its high quality vacancies to several charitable organizations:

Organization

Donation

Recipient

China Hepatitis Prevention Foundation

 Bilive™, Hepatitis A&B vaccine
1.0 million doses

Migrant Laborers' Children in Beijing

Chinese Center for Disease Control and Prevention

Healive™, Hepatitis A vaccine
2.3 million doses

Flooding Areas covering 13 provinces

Disease Prevention Center of Tianjin

Hepatitis A vaccine
(Market Value = RMB 18,000)

Tianjin SOS Children's Village

The Social Welfare Institute of Tangshan

Hepatitis A vaccine
(Market Value = RMB 6,000 )

61 Children at the Social Welfare Institute of Tangshan

 
 
Copyright © 2001-2008 Sinovac Biotech Ltd. All rights reserved.